+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Complement C5 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C5 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Rhinosinusitis With Nasal Polyps - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Rhinosinusitis With Nasal Polyps - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Biologics Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Biologics Market - Forecasts from 2024 to 2029

  • Report
  • April 2024
  • 121 Pages
  • Global
From
From
From
From
From
Biopharmaceuticals Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Biopharmaceuticals Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025 - Product Thumbnail Image

Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastric Cancer Diagnostic Procedure Market Report 2026 - Product Thumbnail Image

Gastric Cancer Diagnostic Procedure Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator